Reverse isolation and gut decontamination in the management of cancer patients.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications / Q000517:prevention & control*; D006801:Humans; D007422:Intestines / Q000382:microbiology*; D009369:Neoplasms / Q000150:complications*; D010356:Patient Isolation
D000900:Anti-Bacterial Agents